BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23845170)

  • 1. Evaluation of ovarian function in 35-40-year-old women with polycystic ovary syndrome.
    de Guevara AL; Crisosto N; Echiburú B; Preisler J; Vantman N; Bollmann J; Pérez-Bravo F; Sir-Petermann T
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):165-70. PubMed ID: 23845170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling.
    Weerakiet S; Lertvikool S; Tingthanatikul Y; Wansumrith S; Leelaphiwat S; Jultanmas R
    Gynecol Endocrinol; 2007; 23(8):455-60. PubMed ID: 17852413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters.
    Jin J; Ruan X; Hua L; Tian X; Li Y; Wang L; Mueck AO
    Gynecol Endocrinol; 2017 Sep; 33(9):694-697. PubMed ID: 28412857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS; Coffler MS; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
    Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
    Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
    Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome.
    Cui Y; Shi Y; Cui L; Han T; Gao X; Chen ZJ
    Fertil Steril; 2014 Jul; 102(1):230-236.e2. PubMed ID: 24746743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K; Zander-Fox D
    Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
    Kushnir VA; Halevy N; Barad DH; Albertini DF; Gleicher N
    J Ovarian Res; 2015 Jul; 8():45. PubMed ID: 26156856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.
    Köninger A; Koch L; Edimiris P; Enekwe A; Nagarajah J; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential rate in decline in ovarian reserve markers in women with polycystic ovary syndrome compared with control subjects: results of a longitudinal study.
    Ahmad AK; Kao CN; Quinn M; Lenhart N; Rosen M; Cedars MI; Huddleston H
    Fertil Steril; 2018 Mar; 109(3):526-531. PubMed ID: 29428308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients.
    Aleyasin A; Aghahoseini M; Mokhtar S; Fallahi P
    Acta Med Iran; 2011; 49(11):715-20. PubMed ID: 22131240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
    Petermann TS; Cartes A; Maliqueo M; Vantman D; Gutiérrez C; Toloza H; Echiburú B; Recabarren SE
    Hum Reprod; 2004 Dec; 19(12):2742-7. PubMed ID: 15358722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-Müllerian hormone as an indicator of reproductive health in women with obesity and concomitant polycystic ovary syndrome].
    Durmanova AK; Otarbaev NK
    Ter Arkh; 2016; 88(12):41-44. PubMed ID: 28139558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.